Join the 200th Anniversary Celebration

Original Article

Benefit of Atrial Pacing in Sleep Apnea Syndrome

Stephane Garrigue, M.D., Philippe Bordier, M.D., Pierre Jaïs, M.D., Dipen C. Shah, M.D., Meleze Hocini, M.D., Chantal Raherison, M.D., Manuel Tunon De Lara, M.D., Michel Haïssaguerre, M.D., and Jacques Clementy, M.D.

N Engl J Med 2002; 346:404-412February 7, 2002

Abstract

Background

Many patients with sleep apnea syndrome have nocturnal bradycardia, paroxysmal tachyarrhythmias, or both, which can be prevented by permanent atrial pacing. We evaluated the effect of using cardiac pacing to increase the heart rate during sleep in patients with sleep apnea syndrome.

Methods

We studied 15 patients (11 men and 4 women; mean [±SD] age, 69±9 years) with central or obstructive sleep apnea who had received permanent atrial-synchronous ventricular pacemakers for symptomatic sinus bradycardia. All patients underwent three polysomnographic evaluations on consecutive nights, the first night for base-line evaluation and then, in random order, one night in spontaneous rhythm and one in dual-chamber pacing mode with atrial overdrive (basic rate, 15 beats per minute faster than the mean nocturnal sinus rate). The total duration and number of episodes of central or obstructive sleep apnea or hypopnea were analyzed and compared.

Results

The mean 24-hour sinus rate during spontaneous rhythm was 57±5 beats per minute at base line, as compared with 72±3 beats per minute with atrial overdrive pacing (P<0.001). The total duration of sleep was 321±49 minutes in spontaneous rhythm, as compared with 331±46 minutes with atrial overdrive pacing (P=0.48). The hypopnea index (the total number of episodes of hypopnea divided by the number of hours of sleep) was reduced from 9±4 in spontaneous rhythm to 3±3 with atrial overdrive pacing (P<0.001). For both apnea and hypopnea, the value for the index was 28±22 in spontaneous rhythm, as compared with 11±14 with atrial overdrive pacing (P<0.001).

Conclusions

In patients with sleep apnea syndrome, atrial overdrive pacing significantly reduces the number of episodes of central or obstructive sleep apnea without reducing the total sleep time.

Media in This Article

Figure 3Effect in the 15 Patients of Atrial Overdrive Pacing on Episodes of Central Sleep Apnea (Panel A) and Episodes of Obstructive Sleep Apnea (Panel B).
Figure 2Polysomnographic Recordings in a Patient with Predominantly Obstructive Apnea Obtained with the Pacemaker Programmed to a Fixed Basic Rate of 40 Beats per Minute (No-Pacing Phase) (Panel A) and with Atrial Overdrive Pacing at 75 Beats per Minute (Pacing Phase) (Panel B).
Article

Sleep apnea syndrome is a common and often undiagnosed disorder associated with substantial cardiovascular morbidity and mortality.1-8 Other consequences include an increased incidence of traffic accidents,9-11 social and family disruption,9,10,12 and bradyarrhythmias or tachyarrhythmias.13-15 Treatments such as nasal continuous positive airway pressure16-18 and oral administration of theophylline19 reduce the number of episodes of apnea but produce side effects such as palpitations. Surgical therapy involving the ablation of tissue, such as uvulopalatopharyngoplasty,20,21 has also been proposed for patients with apnea that is predominantly obstructive.

We observed that some patients who had received a pacemaker with atrial overdrive pacing in order to reduce the incidence of atrial tachyarrhythmias22,23 reported a reduction in breathing disorders after the implantation of the pacemaker. We therefore undertook a study to investigate the efficacy of atrial overdrive pacing in the treatment of sleep apnea syndrome in consecutive patients who required a pacemaker for conventional indications.

Methods

Study Population

A total of 152 patients with dual-chamber pacemakers that had been implanted at least one year previously were screened. A total of 47 patients with problems related to sleep-disordered breathing, snoring, daytime sleepiness, frequent arousals at night, sleep apnea, or some combination of these symptoms were asked to undergo polysomnography in a sleep laboratory. Of these 47 patients, 26 provided written informed consent, and in 15 of them, polysomnographic recordings revealed sleep apnea syndrome, as defined by an apnea index (the total number of episodes of apnea divided by the number of hours of sleep) of 5 or higher and an apnea–hypopnea index (the total number of episodes of either apnea or hypopnea divided by the number of hours of sleep) of 15 or higher.24-26 These 15 patients, who did not engage in regular physical exercise, presented with snoring, daytime sleepiness, fatigue during the morning, and frequent arousals at night; they became the study group. They had no clinical evidence of heart failure, perhaps because they were sedentary, but 11 patients (73 percent) had a left ventricular ejection fraction on echocardiography ranging from 40 to 56 percent within the six months before the study. None of the patients were dependent on the pacemaker.

Polysomnography

Polysomnography was performed in the sleep laboratory with monitoring that included electroencephalography, electromyography of the chin and legs, electro-oculography, oronasal air-flow tracing, recording of the movement of the chest wall and abdomen, finger oximetry, and electrocardiography with a Holter monitor.27 Air flow was monitored qualitatively with an oronasal thermocouple. An episode of apnea was defined as a complete cessation of air flow for at least 10 seconds.19,27 An episode of hypopnea was defined as a decrease of 50 percent or more in the oronasal air flow associated with a 4 percent decrease in arterial oxyhemoglobin saturation. An obstructive event was recorded if there were rib-cage excursions, abdominal excursions, or both during an episode of apnea. The simultaneous absence of air-flow thermistor tracing and respiratory movements was considered to indicate the presence of central apnea.19,27 The number of episodes of arousal due to disordered breathing per hour of sleep was referred to as the arousal index. All polysomnographic recordings were scored by a pneumologist who was unaware of the pacing configuration and not otherwise involved in the study.

Study Protocol

The 15 patients spent three consecutive nights in the sleep laboratory. Their medications were not changed during the study. All polysomnographic recordings were performed with use of the same procedures. The polysomnographic recording of the first night represents the base line (basic pacing rate, 55 to 60 beats per minute), which established the diagnosis of sleep apnea syndrome. The patients were randomly assigned to undergo one of two sets of procedures on the next night and the other set on the night after that. During one of the two nights, the basic ventricular rate of the pacemaker (not synchronized with the atrial activity) was programmed to 40 beats per minute with the aim of recording spontaneous rhythm for a high percentage of the sleep time in order to assess measures of breathing in the absence of pacing (the no-pacing phase). During the other night, atrial overdrive stimulation was provided at a rate that was 15 beats per minute faster than the mean nocturnal heart rate (recorded by the memory function of the pacemaker during the base-line nocturnal assessment) in order to assess the effect of pacing on breathing (the pacing phase). This level of pacing was chosen on the basis of its therapeutic effect on vagally induced atrial arrhythmias, as reported in recent studies.22,23

Statistical Analysis

Data obtained during the base-line recordings were compared with those obtained during the no-pacing and pacing phases. Values are reported as means ±SD. Because of the small sample size, the Mann–Whitney nonparametric test for paired data was used to compare intrapatient differences between the outcome variables during the no-pacing phase and the outcome variables during the pacing phase. In order to assess the effects of the order of the two phases of the study (assessment of period effects), the patients were divided into two groups — one with no pacing on night 2 and pacing on night 3 and the other with pacing on night 2 and no pacing on night 3. Period-effects analysis was performed by means of the Mann–Whitney nonparametric test for independent samples. This test consisted of comparing the two groups in terms of the mean differences in the data between the pacing phase and the no-pacing phase for each variable studied. A two-tailed P value of less than 0.05 was considered to indicate statistical significance. Calculations were performed with the use of Statistica software (StatSoft, Tulsa, Okla.).

Results

Base-Line Polysomnographic Assessment

The base-line characteristics of the patients are summarized in Table 1Table 1Clinical Characteristics and Sleep-Disordered Breathing Events at Base Line in 15 Patients with a Pacemaker.. Nine patients had sinus node disease (60 percent), and six (40 percent) had bradycardia–tachycardia syndrome. Six patients were randomly assigned to receive no pacing on night 2 and nine to receive no pacing on night 3. The 24-hour mean spontaneous heart rate during the base-line phase was similar for all the patients (57±5 beats per minute). All patients presented with episodes of both obstructive and central apnea; the study group had a higher central-apnea index (12±14) than obstructive-apnea index (7±4), but the difference was not statistically significant (P=0.09) (Table 1). Seven patients (Patients 1 through 7) had apnea that was predominantly obstructive (central-apnea index, 5±4; obstructive-apnea index, 8±4). The other eight patients (Patients 8 through 15) had apnea that was predominantly central (central-apnea index, 18±16; obstructive-apnea index, 6±3) (Table 1). The left ventricular ejection fraction was 56 percent or lower in 11 patients (73 percent) and 65 percent or higher in 4 patients (27 percent). The percentage of total sleep time during which oxyhemoglobin saturation was below 90 percent was 12±8 percent, and the mean arousal index was 21±12.

No-Pacing Phase

Data collected during the no-pacing phase and the pacing phase are shown in Table 2Table 2Sleep-Disordered Breathing Events and Arterial Oxygen Saturation Values during the No-Pacing Phase and the Pacing Phase.. Pacemaker stimulation was used during 1.0±0.5 percent of the no-pacing phase because five patients had short episodes of bradycardia with a heart rate of less than 40 beats per minute. The mean total sleep time during the no-pacing phase was 321±49 minutes, the mean apnea–hypopnea index was 28±22, and the mean arousal index was 18±9.

Pacing Phase with Atrial Overdrive Pacing

Atrial pacing at a rate 15 beats per minute faster than the mean nocturnal heart rate resulted in a significant reduction in the number of episodes of all types of apnea (Table 2). In 13 patients (87 percent), the apnea–hypopnea index was reduced by more than 50 percent. The two remaining patients had smaller reductions in the apnea–hypopnea index: one patient had an index of 21 with no pacing and an index of 12 with pacing (a 43 percent reduction), and the index of the other patient was reduced from 79 to 47 (a 41 percent reduction).

An example of a polysomnographic recording during the no-pacing phase from a patient (Patient 9) who presented with sleep apnea that was predominantly central is shown in Figure 1AFigure 1Polysomnographic Recordings in a Patient with Predominantly Central Apnea Obtained with the Pacemaker Programmed to a Fixed Basic Rate of 40 Beats per Minute (No-Pacing Phase) (Panel A) and with Atrial Overdrive Pacing at 72 Beats per Minute (Pacing Phase) (Panel B).. The heart-rate recording shows large variations, with a heart rate below 50 beats per minute during episodes of apnea and an increased heart rate (up to 100 beats per minute) during arousals. In contrast, the recording in Figure 1B shows a substantial reduction in the number of episodes of central apnea and hypopnea associated with much less variation in the heart rate when the basic pacing rate was set at 72 beats per minute. An example of polysomnographic recordings from a patient (Patient 3) with a large number of episodes of obstructive apnea is shown in Figure 2AFigure 2Polysomnographic Recordings in a Patient with Predominantly Obstructive Apnea Obtained with the Pacemaker Programmed to a Fixed Basic Rate of 40 Beats per Minute (No-Pacing Phase) (Panel A) and with Atrial Overdrive Pacing at 75 Beats per Minute (Pacing Phase) (Panel B).; the number of episodes was markedly reduced when the heart rate was stabilized at 75 beats per minute (Figure 2B).

The effect of atrial overdrive pacing on the obstructive-apnea index and the central-apnea index of each of the 15 patients is shown in Figure 3Figure 3Effect in the 15 Patients of Atrial Overdrive Pacing on Episodes of Central Sleep Apnea (Panel A) and Episodes of Obstructive Sleep Apnea (Panel B).. Regardless of the severity of the sleep apnea syndrome, there was a reduction in both indexes in every patient. The reduction in the number of episodes of apnea and hypopnea was associated with a significant increase in the arterial oxyhemoglobin saturation during sleep, reflected by a reduction of the total sleep time during which the oxygen saturation was less than 90 percent (from 10±6 percent to 6±4 percent, P=0.04) (Table 2), in addition to a significant increase in the lowest oxygen saturation value from 83±8 percent to 87±5 percent (P=0.02). There was also a significant decrease in the number of arousals due to periodic breathing that were recorded on electroencephalography, but the typical Cheyne–Stokes pattern was found only in Patient 10 and was present at all three evaluations.

The statistical analysis revealed only two significant period effects (Table 2): there was a significantly greater reduction in the obstructive-apnea index among patients assigned to pacing on night 3 (P=0.04) and a significantly greater increase in the lowest oxyhemoglobin saturation value among patients assigned to pacing on night 2 (P=0.04).

Cardiac Rhythm

All the patients tolerated the protocol well: the total sleep time was similar at base line and during the pacing and no-pacing phases. The Holter monitor tracing and the recordings of the memory function of the pacemaker revealed a significant increase in the mean nocturnal heart rate during the atrial overdrive (pacing) phase (Table 2). The numbers of episodes of atrial arrhythmia that occurred during the pacing and no-pacing phases were similar. Three patients had an episode of atrial arrhythmia (one lasting 21 minutes, one lasting 35 minutes, and one lasting 6 minutes) during the no-pacing phase, and two patients had such an episode (one lasting 18 minutes and the other lasting 27 minutes) during the pacing phase. There were no differences in the number of isolated premature ventricular contractions per hour of sleep (13±24 at base line, 16±31 during the no-pacing phase, and 12±25 during the pacing phase). Neither ventricular couplets nor episodes of ventricular tachycardia were observed during the base-line assessment or during the pacing or no-pacing phase of the study.

Discussion

Our observations show that in patients with sleep apnea syndrome who have an atrial pacemaker, atrial overdrive pacing significantly reduces the number of episodes of obstructive and central sleep apnea and increases arterial oxyhemoglobin saturation without altering total sleep time. A reduction of more than 50 percent in the number of episodes of apnea and hypopnea was achieved with atrial overdrive pacing in most patients (13 of 15), irrespective of whether they had obstructive or central sleep apnea, and was associated with a reduction in the number of arousals and an increase in arterial oxyhemoglobin saturation. These variables returned to the base-line values defining sleep apnea syndrome when the pacemaker was turned off.

Episodes of apnea are associated with hypoxemia, the retention of carbon dioxide, bradycardia, and a decrease in blood pressure that is, in turn, associated with an increase in vagal tone leading to periodic variations in heart rate.24-27 Our data show that reducing the variations in heart rate markedly reduced the number of episodes of sleep apnea in our study population. These periodic variations in heart rate may result in part from changes in autonomic tone and may influence the incidence of central sleep apnea. Consequently, atrial pacing at a high rate relative to that of spontaneous sinus bradycardia may counteract sustained increases in vagal tone by maintaining sympathetic activity.

This hypothesis is compatible with the results of recent studies28-30 showing the efficacy of atrial overdrive pacing in the treatment of vasovagal syncope. In addition, clinical studies have demonstrated that atrial overdrive pacing can suppress vagally induced episodes of atrial fibrillation.22,23,31 The hypothesis is further supported by a previous study suggesting that the therapeutic effects of theophylline in patients with central sleep apnea may be mediated by adenosine antagonism.32 The beneficial effect of theophylline on sleep apnea syndrome might be at least partially explained by its ability to reduce vagal tone.

In contrast to the effect on central sleep apnea, the mechanism of the amelioration of obstructive sleep apnea by atrial overdrive pacing is not clear. Obstructive apnea is caused mainly by the presence of excessive soft tissue (i.e., the soft palate, the tonsils, and the base of the tongue) or by hypotonia of the pharyngeal muscles during sleep.33-36 We did not expect that atrial overdrive pacing would reduce the obstructive-apnea index, since this type of apnea results primarily from anatomical obstruction. The mechanisms involved remain to be explained.

We observed a reduction of more than 50 percent in the apnea–hypopnea index with atrial overdrive. Thus, in our population of patients with symptomatic bradycardia, cardiac pacing could be considered as an alternative to treatment with continuous positive airway pressure or oral theophylline.16-19,37 The ablation of tissue has been proposed as a surgical method for the treatment of snoring and obstructive apnea. Improvement has been achieved in 38 to 50 percent of the patients who have undergone such a surgical procedure.38-41

In our study, cardiac pacing was effective in patients with symptomatic bradyarrhythmias and frequent variations in heart rate. Whether similar beneficial effects could be achieved with atrial pacing in patients who had no indications for pacemaker implantation (typically, sinus node disease or bradycardia–tachycardia syndrome) remains to be determined. In addition, all but four of our patients presented with a reduced left ventricular ejection fraction. Therefore, our results cannot yet be extrapolated to patients with normal cardiac function who have sleep apnea syndrome, even though our four patients with normal cardiac function had more than a 50 percent reduction in the sleep-apnea index.

Atrial overdrive pacing substantially reduced the number of episodes of central and obstructive apnea in patients with pacemakers that had previously been implanted for the treatment of the sick sinus syndrome or the bradycardia–tachycardia syndrome. Further studies are needed to elucidate the mechanisms involved in achieving these reductions and to assess the precise role of cardiac pacing in preventing symptoms, disability, and death in the general population of patients with sleep apnea syndrome.

Source Information

From the Hôpital Cardiologique du Haut-Lévêque (S.G., P.B., P.J., D.C.S., M. Hocini, M. Haïssaguerre, J.C.) and the Department of Lungs and Respiratory Disease, Hôpital du Haut-Lévêque (C.R., M.T.D.), University of Bordeaux, Bordeaux, France.

Address reprint requests to Dr. Garrigue at the Cardiac Pacing and Clinical Electrophysiology Department, Hôpital Cardiologique du Haut-Lévêque, 19, ave. de Magellan, Pessac, CEDEX 33604, France, or at .

References

References

  1. 1

    Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest 1996;109:659-663
    CrossRef | Web of Science | Medline

  2. 2

    Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 1995;345:1085-1087
    CrossRef | Web of Science | Medline

  3. 3

    Krieger J, Grucker D, Sforza E, Chambron J, Kurtz D. Left ventricular ejection fraction in obstructive sleep apnea: effects of long-term treatment with nasal continuous positive airway pressure. Chest 1991;100:917-921
    CrossRef | Web of Science | Medline

  4. 4

    Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988;94:1200-1204
    CrossRef | Web of Science | Medline

  5. 5

    Roux F, D'Ambrosio C, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000;108:396-402
    CrossRef | Web of Science | Medline

  6. 6

    Veale D, Chailleux E, Hoorelbeke-Ramon A, et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Eur Respir J 2000;15:326-331
    CrossRef | Web of Science | Medline

  7. 7

    Newman AB, Spiekerman CF, Enright P, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. J Am Geriatr Soc 2000;48:115-123
    Web of Science | Medline

  8. 8

    Javaheri S. Central sleep apnea-hypopnea syndrome in heart failure: prevalence, impact, and treatment. Sleep 1996;19:Suppl:S229-S231
    Web of Science | Medline

  9. 9

    Cassel W, Ploch T, Becker C, Dugnus D, Peter JH, von Wichert P. Risk of traffic accidents in patients with sleep-disordered breathing: reduction with nasal CPAP. Eur Respir J 1996;9:2606-2611
    CrossRef | Web of Science | Medline

  10. 10

    Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med 2000;94:87-90
    CrossRef | Web of Science | Medline

  11. 11

    Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J, Cooperative Group Burgos-Santander. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999;340:847-851
    Full Text | Web of Science | Medline

  12. 12

    Findley L, Smith C, Hooper J, Dineen M, Suratt PM. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 2000;161:857-859
    Web of Science | Medline

  13. 13

    Grimm W, Hoffmann J, Menz V, et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996;77:1310-1314
    CrossRef | Web of Science | Medline

  14. 14

    Stegman SS, Burroughs JM, Henthorn RW. Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin Electrophysiol 1996;19:899-904
    CrossRef | Web of Science | Medline

  15. 15

    Becker HF, Koehler U, Stammnitz A, Peter JH. Heart block in patients with sleep apnoea. Thorax 1998;53:Suppl 3:S29-S32
    CrossRef | Web of Science | Medline

  16. 16

    Davies RJ, Harrington KJ, Ormerod OJ, Stradling JR. Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis 1993;147:630-634
    Web of Science | Medline

  17. 17

    Issa FG, Sullivan CE. Reversal of central sleep apnea using nasal CPAP. Chest 1986;90:165-171
    CrossRef | Web of Science | Medline

  18. 18

    Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862-865
    CrossRef | Web of Science | Medline

  19. 19

    Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562-567
    Full Text | Web of Science | Medline

  20. 20

    Fujita S, Conway W, Zorick F, Roth T. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1981;89:923-934
    Web of Science | Medline

  21. 21

    Woodson BT, Wooten MR. Manometric and endoscopic localization of airway obstruction after uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1994;111:38-43
    Web of Science | Medline

  22. 22

    Garrigue S, Barold SS, Cazeau S, et al. Is there a synergic effect of propafenone associated with atrial overdrive pacing for atrial arrhythmia prevention? A randomised crossover study. Heart 2000;83:172-177
    CrossRef | Web of Science | Medline

  23. 23

    Garrigue S, Barold SS, Cazeau S, et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol 1998;21:1751-1759
    CrossRef | Web of Science | Medline

  24. 24

    Guilleminault C, Tilkian AG, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:465-484
    CrossRef | Web of Science | Medline

  25. 25

    Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 1972;8:1159-1172
    Medline

  26. 26

    Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A. Cyclical variation of the heart rate in sleep apnoea syndrome: mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet 1984;1:126-131
    CrossRef | Web of Science | Medline

  27. 27

    Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998;98:1071-1077
    Web of Science | Medline

  28. 28

    Deharo JC, Peyre JP, Ritter PH, Chalvidan T, Le Tallec L, Djiane P. Treatment of malignant primary vasodepressive neurocardiogenic syncope with a rate responsive pacemaker driven by heart contractility. Pacing Clin Electrophysiol 1998;21:2688-2690
    CrossRef | Web of Science | Medline

  29. 29

    Abe H, Iwami Y, Nagatomo T, Miura Y, Nakashima Y. Treatment of malignant neurocardiogenic vasovagal syncope with a rate drop algorithm in dual chamber cardiac pacing. Pacing Clin Electrophysiol 1998;21:1473-1475
    CrossRef | Web of Science | Medline

  30. 30

    Sheldon R. Role of pacing in the treatment of vasovagal syncope. Am J Cardiol 1999;84:Suppl:26Q-32Q
    CrossRef | Web of Science | Medline

  31. 31

    Coumel P, Friocourt P, Mugica J, Attuel P, Leclercq JF. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. Pacing Clin Electrophysiol 1983;6:552-560
    CrossRef | Web of Science | Medline

  32. 32

    Sin DD, Man GC, Jones RL. Central sleep apnea and heart failure. N Engl J Med 2000;342:293-293
    Full Text | Web of Science | Medline

  33. 33

    Hudgel DW. Variable site of airway narrowing among obstructive sleep apnea patients. J Appl Physiol 1986;61:1403-1409
    Web of Science | Medline

  34. 34

    Hillarp B, Nylander G, Rosen I, Wickstrom O. Videoradiography of patients with habitual snoring and/or sleep apnea: technical description and presentation of videoradiographic results during sleep concerning occurrence of apnea, type of apnea and site of obstruction. Acta Radiol 1996;37:307-314
    CrossRef | Web of Science | Medline

  35. 35

    Kuna ST. Respiratory-related activation and mechanical effects of the pharyngeal constrictor muscles. Respir Physiol 2000;119:155-161
    CrossRef | Medline

  36. 36

    Isono S, Tanaka A, Nishino T. Effects of tongue electrical stimulation on pharyngeal mechanics in anaesthetized patients with obstructive sleep apnoea. Eur Respir J 1999;14:1258-1265
    CrossRef | Web of Science | Medline

  37. 37

    Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000;101:392-397
    Web of Science | Medline

  38. 38

    Finkelstein Y, Shapiro-Feinberg M, Stein G, Ophir D. Uvulopalatopharyngoplasty vs laser-assisted uvulopalatoplasty. Arch Otolaryngol Head Neck Surg 1997;123:265-276
    Web of Science | Medline

  39. 39

    Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996;19:156-177
    Web of Science | Medline

  40. 40

    Langin T, Pepin JL, Pendlebury S, et al. Upper airway changes in snorers and mild sleep apnea sufferers after uvulopalatopharyngoplasty (UPPP). Chest 1998;113:1595-1603
    CrossRef | Web of Science | Medline

  41. 41

    Powell NB, Riley RW, Troell RJ, Li K, Blumen MB, Guilleminault C. Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing. Chest 1998;113:1163-1174
    CrossRef | Web of Science | Medline

Citing Articles (104)

Citing Articles

  1. 1

    Kendra Becker, Charles Poon, Jennifer L. Martin. 2012. Sleep Disorders in Geriatric Patients. , 735-748.
    CrossRef

  2. 2

    Thomas Brack, Winfried Randerath, Konrad E. Bloch. (2012) Cheyne-Stokes Respiration in Patients with Heart Failure: Prevalence, Causes, Consequences and Treatments. Respiration 83:2, 165-176
    CrossRef

  3. 3

    Bhavneesh Sharma, David McSharry, Atul Malhotra. (2011) Sleep Disordered Breathing in Patients with Heart Failure: Pathophysiology and Management. Current Treatment Options in Cardiovascular Medicine 13:6, 506-516
    CrossRef

  4. 4

    Nalaka S. Gooneratne. 2011. Sleep apnea in older adults. , 399-417.
    CrossRef

  5. 5

    Shahrokh Javaheri. 2011. Heart Failure. , 1400-1415.
    CrossRef

  6. 6

    Charles W. Atwood, Patrick J. Strollo, Rachel Givelber. 2011. Medical Therapy for Obstructive Sleep Apnea. , 1219-1232.
    CrossRef

  7. 7

    Laszlo Littmann, Ross M. Nesbit, J. Matthew Blackwell. (2010) “Awakenings”: Electrocardiographic Findings in Central Sleep Apnea. Annals of Noninvasive Electrocardiology 15:4, 387-391
    CrossRef

  8. 8

    Kim H Chan, Ian Wilcox. (2010) Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Review of Cardiovascular Therapy 8:7, 981-994
    CrossRef

  9. 9

    S. Javaheri. (2010) Central Sleep Apnea. Clinics in Chest Medicine 31:2, 235-248
    CrossRef

  10. 10

    Bernardo Selim, Christine Won, H. Klar Yaggi. (2010) Cardiovascular Consequences of Sleep Apnea. Clinics in Chest Medicine 31:2, 203-220
    CrossRef

  11. 11

    Bhavneesh Sharma, Robert Owens, Atul Malhotra. (2010) Sleep in Congestive Heart Failure. Medical Clinics of North America 94:3, 447-464
    CrossRef

  12. 12

    Christian Binggeli, Isabella Sudano, Roberto Corti, Lukas Spieker, Rolf Jenni, Thomas F Lüscher, Georg Noll. (2010) Spontanous periodic breathing is associated with sympathetic hyperreactivity and baroreceptor dysfunction in hypertension. Journal of Hypertension 28:5, 985-992
    CrossRef

  13. 13

    Mehmood Butt, Girish Dwivedi, Omer Khair, Gregory Y.H. Lip. (2010) Obstructive sleep apnea and cardiovascular disease. International Journal of Cardiology 139:1, 7-16
    CrossRef

  14. 14

    Laila AlDabal, Ahmed S. BaHammam. (2010) Cheyne-Stokes Respiration in Patients with Heart Failure. Lung 188:1, 5-14
    CrossRef

  15. 15

    Hidetoshi Abe, Masafumi Takahashi, Hironobu Yaegashi, Seiichiro Eda, Hideo Tsunemoto, Mamoru Kamikozawa, Jun Koyama, Kyohei Yamazaki, Uichi Ikeda. (2010) Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart and Vessels 25:1, 63-69
    CrossRef

  16. 16

    T. Bitter, D. Horstkotte, O. Oldenburg. (2009) Therapie der Cheyne-Stokes-Atmung bei Herzinsuffizienz. Somnologie - Schlafforschung und Schlafmedizin 13:4, 204-210
    CrossRef

  17. 17

    CUI-LIAN WENG, QIANG CHEN, YAN-LIANG MA, QUAN-YING HE. (2009) A Meta-Analysis of the Effects of Atrial Overdrive Pacing on Sleep Apnea Syndrome. Pacing and Clinical Electrophysiology 32:11, 1434-1443
    CrossRef

  18. 18

    Samuel L. Krachman, Gilbert E. D’Alonzo, Irene Permut, Wissam Chatila. (2009) Treatment of sleep disordered breathing in congestive heart failure. Heart Failure Reviews 14:3, 195-203
    CrossRef

  19. 19

    A. Baranchuk, J. S. Healey, C. S. Simpson, D. P. Redfearn, C. A. Morillo, S. J. Connolly, M. Fitzpatrick. (2009) Atrial overdrive pacing in sleep apnoea: a meta-analysis. Europace 11:8, 1037-1040
    CrossRef

  20. 20

    J-P Baguet, G Barone-Rochette, J-L Pépin. (2009) Hypertension and obstructive sleep apnoea syndrome: current perspectives. Journal of Human Hypertension 23:7, 431-443
    CrossRef

  21. 21

    ANIL-MARTIN SINHA, ALEXANDER BAUER, ERIC C. SKOBEL, KAI-U MARKUS, GUIDO RITSCHER, GEORG NOELKER, OLE-ALEXANDER BREITHARDT, JOHANNES BRACHMANN, CHRISTOPH STELLBRINK. (2009) Long-Term Effects of Dynamic Atrial Overdrive Pacing on Sleep-Related Breathing Disorders in Pacemaker or Cardioverter Defibrillator Recipients. Pacing and Clinical Electrophysiology 32, S219-S222
    CrossRef

  22. 22

    B. Braga, D. Poyares, F. Cintra, C. Guilleminault, C. Cirenza, S. Horbach, D. Macedo, R. Silva, S. Tufik, A.A.V. De Paola. (2009) Sleep-disordered breathing and chronic atrial fibrillation. Sleep Medicine 10:2, 212-216
    CrossRef

  23. 23

    L. Luthje, B. Renner, R. Kessels, D. Vollmann, T. Raupach, B. Gerritse, S. Tasci, J. O. Schwab, M. Zabel, D. Zenker, P. Schott, G. Hasenfuss, C. Unterberg-Buchwald, S. Andreas. (2009) Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea. European Journal of Heart Failure 11:3, 273-280
    CrossRef

  24. 24

    T Douglas Bradley, John S Floras. (2009) Obstructive sleep apnoea and its cardiovascular consequences. The Lancet 373:9657, 82-93
    CrossRef

  25. 25

    Danny J. Eckert, Atul Malhotra, Amy S. Jordan. (2009) Mechanisms of Apnea. Progress in Cardiovascular Diseases 51:4, 313-323
    CrossRef

  26. 26

    Sudhansu Chokroverty. 2009. Sleep Disturbances in General Medical Disorders. , 550-580.
    CrossRef

  27. 27

    Satish Bhadriraju, Carlton R. Kemp, Mani Cheruvu, Srinivas Bhadriraju. (2008) Sleep Apnea Syndrome. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 7:4, 248-253
    CrossRef

  28. 28

    Christoph Lissel, Sabrina Hennigs, Birgit Hoffmann-Castendiek, Ajmal Gardiwal, Hanno Oswald, Tobias Welte, Gunnar Klein. (2008) Effect of Restoring Sinus Rhythm on Sleep Apnea in Patients With Atrial Fibrillation or Flutter. The American Journal of Cardiology 102:6, 709-711
    CrossRef

  29. 29

    Shahrokh Javaheri. (2008) Sleep dysfunction in heart failure. Current Treatment Options in Neurology 10:5, 323-335
    CrossRef

  30. 30

    E. N. Simantirakis, S. E. Schiza, N. S. Siafakas, P. E. Vardas. (2008) Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy. Europace 10:9, 1029-1033
    CrossRef

  31. 31

    Virend K. Somers, David P. White, Raouf Amin, William T. Abraham, Fernando Costa, Antonio Culebras, Stephen Daniels, John S. Floras, Carl E. Hunt, Lyle J. Olson, Thomas G. Pickering, Richard Russell, Mary Woo, Terry Young. (2008) Sleep Apnea and Cardiovascular Disease. Journal of the American College of Cardiology 52:8, 686-717
    CrossRef

  32. 32

    I. H. Stevenson, H. Teichtahl, D. Cunnington, S. Ciavarella, I. Gordon, J. M. Kalman. (2008) Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. European Heart Journal 29:13, 1662-1669
    CrossRef

  33. 33

    Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N. A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Heart Rhythm 5:6, e1-e62
    CrossRef

  34. 34

    Anjali H Anselm, Nadine Gauthier, Rob SB Beanlands, Haissam Haddad. (2008) Sleep apnea in chronic heart failure. Current Opinion in Internal Medicine 7:3, 220-225
    CrossRef

  35. 35

    Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Journal of the American College of Cardiology 51:21, e1-e62
    CrossRef

  36. 36

    Kitti Barta, Zoltán Szabó, Csaba Kun, Csaba Munkácsy, Tünde Magyar, Orsolya Bene, László Csiba, István Lőrincz. (2008) Szívritmuszavarok obstruktív alvási apnoéban. Orvosi Hetilap 149:13, 579-587
    CrossRef

  37. 37

    Anjali H Anselm, Nadine Gauthier, Rob SB Beanlands, Haissam Haddad. (2008) Sleep apnea in chronic heart failure. Current Opinion in Cardiology 23:2, 121-126
    CrossRef

  38. 38

    Lars Lüthje, Stefan Andreas. (2008) Obstructive sleep apnea and coronary artery disease. Sleep Medicine Reviews 12:1, 19-31
    CrossRef

  39. 39

    Tomotaka Dohi, Takatoshi Kasai, Koji Narui, Sugao Ishiwata, Minoru Ohno, Tetsu Yamaguchi, Shin-ichi Momomura. (2008) Bi-Level Positive Airway Pressure Ventilation for Treating Heart Failure With Central Sleep Apnea That is Unresponsive to Continuous Positive Airway Pressure. Circulation Journal 72:7, 1100-1105
    CrossRef

  40. 40

    Haitham M. Al-Angari, Alan V. Sahakian. (2007) Use of Sample Entropy Approach to Study Heart Rate Variability in Obstructive Sleep Apnea Syndrome. IEEE Transactions on Biomedical Engineering 54:10, 1900-1904
    CrossRef

  41. 41

    MIGUEL A. ARIAS, ANA M. SÁNCHEZ. (2007) Obstructive Sleep Apnea and its Relationship to Cardiac Arrhythmias. Journal of Cardiovascular Electrophysiology 18:9, 1006-1014
    CrossRef

  42. 42

    Jacques Clementy, Pierre Bordachar, Sylvain Reuter, Antoine Deplagne, Philippe Bordier. (2007) Troubles du rythme cardiaque dans le syndrome d'apnée du sommeil. La Presse Médicale 36:6, 1012-1015
    CrossRef

  43. 43

    Katsuhisa Banno, Meir H. Kryger. (2007) Sleep apnea: Clinical investigations in humans. Sleep Medicine 8:4, 400-426
    CrossRef

  44. 44

    Thierry Badoual, Luc Hittinger, Marie-Pia d'Ortho. (2007) Syndrome d'apnées du sommeil et insuffisance cardiaque. La Presse Médicale 36:6, 990-998
    CrossRef

  45. 45

    Miguel A. Arias, Francisco García-Río, Alberto Alonso-Fernández, Ana M. Sánchez. (2007) Síndromes de apneas-hipopneas durante el sueño e insuficiencia cardiaca. Revista Española de Cardiología 60:4, 415-427
    CrossRef

  46. 46

    Timothy J. Barreiro, David J. Gemmel. (2007) Noninvasive Ventilation. Critical Care Clinics 23:2, 201-222
    CrossRef

  47. 47

    Timothy A. Connolly, Amir Sharafkhaneh. (2007) Sleep-Related Breathing Disorder and Heart Disease—Central Sleep Apnea. Sleep Medicine Clinics 2:1, 107-117
    CrossRef

  48. 48

    Alaa A. Shalaby, Charles W. Atwood, Claudius Hansen, Martin Konermann, Roger Freedman, Jeffrey Fowler, Robert Simpson, Michel A. Cramer Bornemann, Jonathan Kwok, Yachuan Pu, Kent Lee, Jesse Hartley, Roger Willems, Joerg Neuzner. (2007) Analysis of Interaction of Acute Atrial Overdrive Pacing with Sleep-Related Breathing Disorder. The American Journal of Cardiology 99:4, 573-578
    CrossRef

  49. 49

    2007. S. , 186-203.
    CrossRef

  50. 50

    B.A. Phillips. (2007) Atrial Overdrive Pacing for the Obstructive Sleep Apnea-Hypopnea Syndrome. Yearbook of Pulmonary Disease 2007, 283-284
    CrossRef

  51. 51

    A. Verma. (2007) Atrial Overdrive Pacing for the Obstructive Sleep Apnea-Hypopnea Syndrome. Yearbook of Neurology and Neurosurgery 2007, 149-150
    CrossRef

  52. 52

    B.A. Phillips. (2007) Atrial Overdrive Pacing in Patients With Sleep Apnea With Implanted Pacemaker. Yearbook of Pulmonary Disease 2007, 284-285
    CrossRef

  53. 53

    Amir Sharafkhaneh, Hossein Sharafkhaneh, Audrius Bredikus, Christian Guilleminault, Byikem Bozkurt, Max Hirshkowitz. (2007) Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Medicine 8:1, 31-36
    CrossRef

  54. 54

    Fred M. Kusumoto, Nora Goldschlager. (2006) Implantable cardiac arrhythmia devices-part I: Pacemakers. Clinical Cardiology 29:5, 189-194
    CrossRef

  55. 55

    (2006) Sleep Apnea and Heart Disease. New England Journal of Medicine 354:10, 1086-1089
    Full Text

  56. 56

    OSWALDO T. GRECO, LIA R.A. BITTENCOURT, REMY N.A. VARGAS, MOACIR A. BORGES, JOSE C.P. MATEOS, AUGUSTO CARDINALLI NETO, ORMUZ D.C. COELHO, ROGERIO S. SILVA, ROSANA A. MAZZO, DOUGLAS M.B. MELATTO, SERGIO TUFIK, PAULO R.A. GAUCH. (2006) Sleep Parameters in Patients Using Pacemakers with Sleep Rate Function on. Pacing and Clinical Electrophysiology 29:2, 135-141
    CrossRef

  57. 57

    Jean-Louis Pépin, Nathalie Chouri-Pontarollo, Renaud Tamisier, Patrick Lévy. (2006) Cheyne–Stokes respiration with central sleep apnoea in chronic heart failure: Proposals for a diagnostic and therapeutic strategy. Sleep Medicine Reviews 10:1, 33-47
    CrossRef

  58. 58

    E Kasasbeh, David S. Chi, G Krishnaswamy. (2006) Inflammatory Aspects of Sleep Apnea and Their Cardiovascular Consequences. Southern Medical Journal 99:1, 58-67
    CrossRef

  59. 59

    Joaquín Terán Santos, María L. Alonso Álvarez. (2006) El corazón, el sueño y la respiración. Revista Española de Cardiología 59:1, 5-8
    CrossRef

  60. 60

    Andrew D. Krahn, Raymond Yee, Mark K. Erickson, Toby Markowitz, Lorne J. Gula, George J. Klein, Allan C. Skanes, Charles F.P. George, Kathleen A. Ferguson. (2006) Physiologic Pacing in Patients With Obstructive Sleep Apnea. Journal of the American College of Cardiology 47:2, 379-383
    CrossRef

  61. 61

    H. Erhan Dincer, William O&rsquo;Neill. (2006) Deleterious Effects of Sleep-Disordered Breathing on the Heart and Vascular System. Respiration 73:1, 124-130
    CrossRef

  62. 62

    Ramón García Calabozo, José Martínez Ferrer, María J. Sancho-Tello de Carranza. (2006) Temas de actualidad en estimulación cardíaca 2005. Revista Española de Cardiología 59, 66-77
    CrossRef

  63. 63

    Kathryn E. McGoldrick. 2006. Eye, Ear, Nose, and Throat Diseases. , 1-27.
    CrossRef

  64. 64

    Julio Martí Almor, Miguel Félez Flor, Eva Balcells, Mercedes Cladellas, Joan Broquetas, Jordi Bruguera. (2006) Prevalencia del síndrome de apnea obstructiva del sueño en pacientes con disfunción sinusal. Revista Española de Cardiología 59:1, 28-32
    CrossRef

  65. 65

    Gottlieb, Daniel J., . (2005) Can Sleep Apnea Be Treated without Modifying Anatomy?. New England Journal of Medicine 353:24, 2604-2606
    Full Text

  66. 66

    Simantirakis, Emmanuel N., Schiza, Sophia E., Chrysostomakis, Stavros I., Chlouverakis, Gregory I., Klapsinos, Nikolaos C., Siafakas, Nikolaos M., Vardas, Panos E., . (2005) Atrial Overdrive Pacing for the Obstructive Sleep Apnea–Hypopnea Syndrome. New England Journal of Medicine 353:24, 2568-2577
    Full Text

  67. 67

    MOHAMMAD-REZA MOVAHED, MEHRDAD JALILI, NAFIZ KICIMAN. (2005) Cardiovascular Abnormalities and Arrhythmias in Patients with Ondine's Curse (Congenital Central Hypoventilation) Syndrome. Pacing and Clinical Electrophysiology 28:11, 1226-1230
    CrossRef

  68. 68

    Rohit Budhiraja, Stuart F Quan. (2005) Sleep-disordered breathing and cardiovascular health. Current Opinion in Pulmonary Medicine 11:6, 501-506
    CrossRef

  69. 69

    Geoffrey S Gilmartin, Robert W Daly, Robert J Thomas. (2005) Recognition and management of complex sleep-disordered breathing. Current Opinion in Pulmonary Medicine 11:6, 485-493
    CrossRef

  70. 70

    Fred Kusumoto, Nora Goldschlager. (2005) Beyond Heart Rhythms: New Directions for Implantable Devices. Journal of Interventional Cardiac Electrophysiology 14:1, 5-7
    CrossRef

  71. 71

    John J. Harrington, Alon Y. Avidan. (2005) Treatment of sleep disorders in elderly patients. Current Treatment Options in Neurology 7:5, 339-352
    CrossRef

  72. 72

    S. Sundar, R.P. Symonds, C. Deehan. (2005) Radiotherapy to patients with artificial cardiac pacemakers. Cancer Treatment Reviews 31:6, 474-486
    CrossRef

  73. 73

    Anne M. Gillis, Rik Willems. (2005) Controversies in pacing: Indications and programming. Current Cardiology Reports 7:5, 336-341
    CrossRef

  74. 74

    ZHENG-GUI HUANG, XIN WANG, OLGA DERGACHEVA, DAVID MENDELOWITZ. (2005) Prenatal Nicotine Exposure Recruits an Excitatory Pathway to Brainstem Parasympathetic Cardioinhibitory Neurons during Hypoxia/Hypercapnia in the Rat: Implications for Sudden Infant Death Syndrome. Pediatric Research 58:3, 562-567
    CrossRef

  75. 75

    Shahrokh Javaheri, Laura Wexler. (2005) Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Current Treatment Options in Cardiovascular Medicine 7:4, 295-306
    CrossRef

  76. 76

    Alaa A. Shalaby. (2005) Implantable Pacing Devices and Sleep Apnea: Implications for Diagnosis and Therapy. Congestive Heart Failure 11:2, 80-86
    CrossRef

  77. 77

    C. Evans, J. Wang, R. Neff, D. Mendelowitz. (2005) Hypoxia recruits a respiratory-related excitatory pathway to brainstem premotor cardiac vagal neurons in animals exposed to prenatal nicotine. Neuroscience 133:4, 1073-1079
    CrossRef

  78. 78

    (2005) Tratamiento médico del SAHS. Archivos de Bronconeumología 41, 45-50
    CrossRef

  79. 79

    Shahrokh Javaheri. 2005. Heart Failure. , 1208-1217.
    CrossRef

  80. 80

    HARUHIKO ABE, TAKURO KITAMURA, YASUSHI OGINOSAWA, YASUHIDE NAKASHIMA. (2004) Alleviation of Central Sleep Apnea by Ventricular Pacing in a Patient with an Implanted Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:10, 1447-1448
    CrossRef

  81. 81

    G. S. Hamilton, P. Solin, M. T. Naughton. (2004) Obstructive sleep apnoea and cardiovascular disease. Internal Medicine Journal 34:7, 420-426
    CrossRef

  82. 82

    Anil-Martin Sinha, Erik C Skobel, Ole-Alexander Breithardt, Christine Norra, Kai U Markus, Christian Breuer, Peter Hanrath, Christoph Stellbrink. (2004) Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. Journal of the American College of Cardiology 44:1, 68-71
    CrossRef

  83. 83

    Richard B. Berry, Susan M. Harding. (2004) Sleep and medical disorders. Medical Clinics of North America 88:3, 679-703
    CrossRef

  84. 84

    STEPHANE GARRIGUE, PHILIPPE BORDIER, S. SERGE BAROLD, JACQUES CLEMENTY. (2004) Sleep Apnea:. A New Indication for Cardiac Pacing?. Pacing and Clinical Electrophysiology 27:2, 204-211
    CrossRef

  85. 85

    Mary A. Woo, Gregg C. Fonarow. (2003) Sleep-disordered breathing in heart failure. Current Treatment Options in Cardiovascular Medicine 5:6, 459-467
    CrossRef

  86. 86

    Matthew T. Naughton. (2003) Sleep disorders in patients with congestive heart failure. Current Opinion in Pulmonary Medicine 9:6, 453-458
    CrossRef

  87. 87

    Felix Kreier, Andries Kalsbeek, Marieke Ruiter, Ajda Yilmaz, Johannes A Romijn, Hans P Sauerwein, Eric Fliers, Ruud M Buijs. (2003) Central nervous determination of food storage—a daily switch from conservation to expenditure: implications for the metabolic syndrome. European Journal of Pharmacology 480:1-3, 51-65
    CrossRef

  88. 88

    S Garrigue, P Bordier, J Clémenty. (2003) Apnées du sommeil et stimulation cardiaque : mécanismes d’action et perspectives. Annales de Cardiologie et d'Angéiologie 52:4, 239-245
    CrossRef

  89. 89

    J.-P Baguet, J.-L Pépin, L Hammer, P Lévy, J.-M Mallion. (2003) Conséquences cardiovasculaires du syndrome d’apnées obstructives du sommeil. La Revue de Médecine Interne 24:8, 530-537
    CrossRef

  90. 90

    Hans-Werner Duchna, Ludger Grote, Stefan Andreas, Richard Schulz, Thomas E. Wessendorf, Heinrich F. Becker, Peter Clarenbach, Ingo Fietze, Holger Hein, Ulrich Koehler, Andreas Nachtmann, Winfried Randerath, Kurt Rasche, Karl-Heinz Ruhle, Bernd Sanner, Harald Schafer, Richard Staats, Volker Topfer. (2003) Sleep-Disordered Breathing and Cardio- and Cerebrovascular Diseases: 2003 Update of Clinical Significance and Future Perspectives. Schlafbezogene Atmungsstorungen und kardio- und zerebrovaskulare Erkrankungen: Update 2003 der klinischen Bedeutung und zukunftiger Entwicklungen. Somnologie 7:3, 101-121
    CrossRef

  91. 91

    Mary Marzec, Jonathan Edwards, Oren Sagher, Gail Fromes, Beth A. Malow. (2003) Effects of Vagus Nerve Stimulation on Sleep-related Breathing in Epilepsy Patients. Epilepsia 44:7, 930-935
    CrossRef

  92. 92

    Paola A. Lanfranchi, Virend K. Somers. (2003) Sleep-disordered breathing in heart failure: characteristics and implications. Respiratory Physiology & Neurobiology 136:2-3, 153-165
    CrossRef

  93. 93

    Phyllis K. Stein, Stephen P. Duntley, Peter P. Domitrovich, Pallavi Nishith, Robert M. Carney. (2003) A Simple Method to Identify Sleep Apnea Using Holter Recordings. Journal of Cardiovascular Electrophysiology 14:5, 467-473
    CrossRef

  94. 94

    J.o-Dee L Lattimore, David S Celermajer, Ian Wilcox. (2003) Obstructive sleep apnea and cardiovascular disease. Journal of the American College of Cardiology 41:9, 1429-1437
    CrossRef

  95. 95

    Martha R SHEPERTYCKY, Mohammed AL-BARRAK, Meir H. KRYGER. (2003) Morbidity and mortality in obstructive sleep apnea syndrome 1: Effect of treatment on cardiovascular morbidity. Sleep and Biological Rhythms 1:1, 15-28
    CrossRef

  96. 96

    L. Fauchier. (2003) L'année 2002 en rythmologie : pour des changements radicaux ?. Annales de Cardiologie et d'Angéiologie 52:1, 52-55
    CrossRef

  97. 97

    Kathryn E. McGoldrick. (2002) Whatʼs new in our understanding of obstructive sleep apnea?. Current Opinion in Anaesthesiology 15:6, 605-607
    CrossRef

  98. 98

    Michael E. Bourke, Jeffrey S. Healey. (2002) Pacemakers, recent directions and developments. Current Opinion in Anaesthesiology 15:6, 681-686
    CrossRef

  99. 99

    Bradley G. Phillips, Virend K. Somers. (2002) Sleep disordered breathing and risk factors for cardiovascular disease. Current Opinion in Pulmonary Medicine 8:6, 516-520
    CrossRef

  100. 100

    Sevag Bananian, Stuart G. Lehrman, George P. Maguire. (2002) Cardiovascular Consequences of Sleep-related Breathing Disorders. Heart Disease 4:5, 296-305
    CrossRef

  101. 101

    (2002) Atrial Pacing in Sleep Apnea Syndrome. New England Journal of Medicine 347:6, 445-446
    Full Text

  102. 102

    Kathryn E. McGoldrick. (2002) Therapeutic Electrical Stimulation of the Hypoglossal Nerve in Obstructive Sleep Apnea. Survey of Anesthesiology 46:4, 238-239
    CrossRef

  103. 103

    Gottlieb, Daniel J., . (2002) Cardiac Pacing — A Novel Therapy for Sleep Apnea?. New England Journal of Medicine 346:6, 444-445
    Full Text

  104. 104

    Drazen, Jeffrey M., . (2002) Sleep Apnea Syndrome. New England Journal of Medicine 346:6, 390-390
    Full Text

Letters